510(k) Report

510(k) · Cleared

Cleared

Cormet Cementless Resurfacing Femoral Head

K092198510(k) TraditionalCleared Apr 15, 2010268-day reviewClass II21 CFR 888.3400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Corin USA · KXA Prosthesis, Hip, Femoral, Resurfacing

Cleared on Apr 15, 2010 as substantially equivalent to K994153 (Corin USA, 2000) and 1 other predicate after a 268-day review. Its family tree reaches back 4 generations to 1998.

Decided
Apr 15, 2010
Review
268 days
Class
Class II
Product code
KXA
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K983452 (1998). 6 ancestors in all, the oldest K811718 (1981). No later device cites it as a predicate yet.

  1. Root · 4 generations backK983452 Nelson Resurfacing HeadBiomet, Inc. · 1998
  2. 3 generations backK021799 Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc. · 2002
  3. 2 generations backK023188 Press-Fit Head Resurfacing DeviceBiomet Orthopedics, Inc. · 2002
  4. 1 generation backK071053 Recap HA Press-Fit Femoral Resurfacing HeadBiomet, Inc. · 2007
  5. This deviceK092198 Cormet Cementless Resurfacing Femoral HeadCorin USA · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K983452Nelson Resurfacing HeadBiomet, Inc.1998—
−3K021799Cemented Femoral Head Resurfing DeviceBiomet Orthopedics, Inc.2002—
−2K023188Press-Fit Head Resurfacing DeviceBiomet Orthopedics, Inc.2002—
−1K071053Recap HA Press-Fit Femoral Resurfacing HeadBiomet, Inc.2007—
0 (this device)K092198Cormet Cementless Resurfacing Femoral HeadCorin USA2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
200010
FIG. 1 — Lineage of K092198, 1998–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KXA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KXA device

  1. #1 K201219 Biocore9 Femoral Head Resurfacing Componentscore 0.7 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K994153Cormet 2000 Hemi Hip Metallic Resurfacing Prosthesis
Summary page 1
…(21CFR 888.3400) 7. Legally Marketed Devices to which Substantial Equivalence is claimed: a. Cormiet 2000 Hemi Hip Metallic Resurfacing Prosthesis (K(994153) b. ReCap® HA Press-Fit Femoral Resurfacing Head (K(071053) 8. Device Description: The Cormet Cementle…
Corin USA2000—
*K071053Recap HA Press-Fit Femoral Resurfacing Head
Summary page 1
…Equivalence is claimed: a. Cormiet 2000 Hemi Hip Metallic Resurfacing Prosthesis (K(994153) b. ReCap® HA Press-Fit Femoral Resurfacing Head (K(071053) 8. Device Description: The Cormet Cementless Resurfacing Femoral Head is a femoral component manufactured f…
Biomet, Inc.2007—
†K083312Minihip StemCorin USA2010—

Also cleared against K994153: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 3.6 years on median.
  • None of the 6 ancestors has a recall.
  • 3 other devices also cite its predicate K994153.

How does its category compare?

All KXA devices

KXA Prosthesis, Hip, Femoral, Resurfacing: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · KXA

1in 2021

2007: 22008: 12010: 12021: 1
2007high 2 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KXA

Too few KXA 510(k)s in any year since 2007 to give a median.

Recalls per year · KXA

1in 2012

2007: 22010: 132012: 1
2007high 13 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KXA

14in 2025

2007: 152008: 222009: 112010: 682011: 5932012: 2,0992013: 2,5222014: 2,4312015: 1,6742016: 6212017: 5802018: 4302019: 9712020: 3732021: 172022: 132023: 52024: 22025: 14
2007high 2,522 (2013) · low 2 (2024)2025

MAUDE reports naming product code KXA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—215
20081—022
20090—011
20101—1368
20110—0593
20120—12,099
20130—02,522
20140—02,431
20150—01,674
20160—0621
20170—0580
20180—0430
20190—0971
20200—0373
20211—017
20220—013
20230—05
20240—02
20250—014
20260—0—

What is it indicated for?

The Cormet Cementless Resurfacing Femoral Head is indicated for hemi hip resurfacing arthroplasty in patients with non-inflammatory degenerative joint disease, including osteo and rheumatoid arthritis, post traumatic disease and -avascular necrosis. It is indicated for relief of pain and disability, and to restore hip function within patients who have radiographic evidence of good bone stock in the femoral head and acetzabulum, the bearing surface and…

Read the full statement (123 words)

The Cormet Cementless Resurfacing Femoral Head is indicated for hemi hip resurfacing arthroplasty in patients with non-inflammatory degenerative joint disease, including osteo and rheumatoid arthritis, post traumatic disease and -avascular necrosis.

It is indicated for relief of pain and disability, and to restore hip function within patients who have radiographic evidence of good bone stock in the femoral head and acetzabulum, the bearing surface and supportive bone structure of the acetabulum being normal.

It is intended for patients having deformities of the hip that do not lend themselves to conventional total hip replacement such as:

* previously failed femoral osteotomy, -

* early deformities of the proximal end of the femur.

The Cormet Cementless Resurfacing Femoral Head is indicated for cementiess use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092198: Cormet Cementless Resurfacing Femoral Head.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K092198

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026